Nadia is an accomplished public affairs and regulatory consultant offering a unique perspective in pharma and healthcare having extensively worked for more than 30 years in both the industry and at /with the regulatory government authorities.

Nadia is recognized in her field as a Regulator at MOH-UAE heading the Registration & Pricing and for her contribution in shaping the GCC-UAE regulatory frameworks and guidelines for pharma, medical devices, and clinical research in the GCC.

Nadia later worked for Pfizer Gulf & Levant (2011-2017) and AstraZeneca-ME (2017-2019), leading the functions for Regulatory and Governmental Affairs.

Currently she is a consultant for multinational Pharma (Jan 2019-to date) such as NewBridge pharmaceuticals, Takeda, Abbott, Alnylam, Inibsa, Eurofarma, and others including many local and foriegn manufacturers.

Nadia’s consistent purpose is to raise awareness among authorities and companies on the importance of strengthening the regulatory system for the advancement of the countries and its ECO system.

Nadia has a Bachelor’s degree in Pharmacy from Jordan University (88), a Masters’ degree in Healthcare Management from Zayed University (2008) and a Master’s degree in Public Health (MPH) from John Hopkins University, School of Public Health in Baltimore, USA, (2011), where she has also completed her advanced studies for the Dr PH program (2015).